Association between Health Systems Performance and Treatment Outcomes in Patients Co-Infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: Implications for TB Programmes
Objective To improve the treatment of MDR-TB and HIV co-infected patients, we investigated the relationship between health system performance and patient treatment outcomes at 4 decentralised MDR-TB sites. Methods In this mixed methods case study which included prospective comparative data, we measured health system performance using a framework of domains comprising key health service components. Using Pearson Product Moment Correlation coefficients we quantified the direction and magnitude of the association between health system performance and MDR-TB treatment outcomes. Qualitative data from participant observation and interviews analysed using systematic text condensation (STC) complemented our quantitative findings. Findings We found significant differences in treatment outcomes across the sites with successful outcomes varying from 72% at Site 1 to 52% at Site 4 (p<0.01). Health systems performance scores also varied considerably across the sites. Our findings suggest there is a correlation between treatment outcomes and overall health system performance which is significant (r = 0.99, p<0.01), with Site 1 having the highest number of successful treatment outcomes and the highest health system performance. Although the ‘integration’ domain, which measured integration of MDR-TB services into existing services appeared to have the strongest association with successful treatment outcomes (r = 0.99, p<0.01), qualitative data indicated that the ‘context’ domain influenced the other domains. Conclusion We suggest that there is an association between treatment outcomes and health system performance. The chance of treatment success is greater if decentralised MDR-TB services are integrated into existing services. To optimise successful treatment outcomes, regular monitoring and support are needed at a district, facility and individual level to ensure the local context is supportive of new programmes and implementation is according to guidelines.
Zager E, McNerney R (2008) Multidrug-resistant tuberculosis. BMC Infectious Diseases 8: doi:10.1186/1471-2334-1188-1110.
[3]
Kawonga M, Blaauw D, Fonn S (2012) Aligning vertical interventions to health systems: a case study of the HIV monitoring and evaluation system in South Africa. Health Research Policy and Systems 10.
[4]
Atun R, de Jongh T, Secci F, Ohiri K, Adeyi O (2010) A systematic review of the evidence on integration of targeted health interventions into health systems. Health Policy and Planning 25: 1–14. doi: 10.1093/heapol/czp053
[5]
Rao K, Ramani S, Hazarika I, George S (2013) When do vertical programmes strengthen health systems? A comparative assessment of disease-specific interventions in India. Health Policy and Planning 1–11.
[6]
Nathanson E, Lambregts-van Weezenbeek C, Rich M, Gupta R, Bayona J, et al. (2006) Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 12: 1389–1397. doi: 10.3201/eid1209.051618
[7]
Toczek A, Cox H, du Cros P, Cooke G, Ford N (2013) Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 17: 299–307. doi: 10.5588/ijtld.12.0537
[8]
Brust J, Gandhi N, Carrara H, Osburn G, Padayatchi N (2010) High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000–2003. Int J Tuberc Lung Dis 14: 413–419.
[9]
Farley J, Ram M, Pan W, Waldman S, Cassell G, et al. (2011) Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence. PLoS ONE 6: e20436 doi:20410.21371/journal.pone.0020436.
[10]
Jain A, Dixit P (2008) Multidrug-resistant to extensively drug resistant tuberculosis: what is next? J Biosci 33: 605–616. doi: 10.1007/s12038-008-0078-8
[11]
Loveday M, Wallengren K, Voce A, Margot B, Reddy T, et al. (2012) Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis 16: 209–215. doi: 10.5588/ijtld.11.0401
[12]
Loveday M, Padayatchi N, Roberts J, Voce A, Brust J, et al. Decentralised vs. centralised care for MDR-TB patients: A comparison of final treatment outcomes in KwaZulu-Natal, South Africa; Kuala Lumpur, Malaysia. [Abstract #PC-487-15]. Int J Tuberc Lung Dis 16 (Suppl 1)S136–S137. doi: 10.5588/ijtld.11.0401
[13]
Coker R, Balen J, Mounier-Jack S, Shigayeva A, Lazarus J, et al. (2010) A conceptual and analytical approach to comparative analysis of country case studies: HIV and TB control programmes and health systems integration. Health Policy and Planning 25: i21–i31. doi: 10.1093/heapol/czq054
[14]
Loveday M, Zweigenthal V (2011) TB and HIV integration: obstacles and possible solutions to implementation in South Africa. Trop Med Int Health 16: 431–438. doi: 10.1111/j.1365-3156.2010.02721.x
[15]
Loveday M, Scott V, McCoughlin J, Amien F, Zweigenthal V (2011) Assessing care for patients with TB/HIV/STIs in a rural district in KwaZulu-Natal SAMJ. 101: 887–890.
[16]
Scott V, Chopra M, Azevedo V, Caldwell J, Naidoo P, et al. (2010) Scaling up integration: Development and results of a participatory assessment of HIV/TB services, South Africa Health Research Policy and Systems. 8: 1–11. doi: 10.1186/1478-4505-8-23
[17]
Laserson K, Thorpe L, Leimane V, Weyer K, Mitnick C, et al. (2005) Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 9: 640–645.
[18]
World Health Organisation (2008) Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency Update 2008. WHO/HTM/TB/2008.402. Geneva: World Health Organisation.
[19]
Malterud K (2012) Systematic text condensation: A strategy for qualitative analysis. Scandinavian Journal of Public Health 40: 795. doi: 10.1177/1403494812465030
[20]
May C, Finch T, Mair F, Ballini L, Dowrick C, et al. (2007) Understanding the implementation of complex interventions in health care: the normalization process model. BMC Health Serv Res 7: 148. doi: 10.1186/1472-6963-7-148
[21]
Georgeu D, Colvin C, Lewin S, Fairall L, Bachmann M, et al.. (2012) Implementing nurse-initiated and managed antiretroviral treatment (NIMART) in South Africa: a qualitative process evaluation of the STRETCH trial. Implementation Science 7: doi:10.1186/1748-5908-1187-1166.
[22]
Schneider H, Coetzee D, Van Rensburg D, Gilson L (2010) Differences in antiretroviral scale up in three South African provinces: the role of implementation management. BMC Health Services Research 10: S4 Available: http://www.biomedcentral.com/1472-6963/1？410/S1471/S1474.
[23]
Van Rensburg D (2006) The Free State’s approach to implementing the “Comprehensive Plan,” notes by a participant outsider. Acta Academica Suppl 1: 44–93.
[24]
Atun R, Bataringaya J (2011) Building a Durable Response to HIV/AIDS: Implications for Health Systems. J Acquir Immune Defic Syndr 57: S91–S95. doi: 10.1097/qai.0b013e3182218441
[25]
van Olmen J, Criel B, Bhojani U, Marchal B, van Belle S, et al.. (2012) The Health System Dynamics Framework: The introduction of an analytical model for health system analysis and its application to two case-studies. Health, Culture and Society 2: DOI 10.5195/hcs.2012.5171.
[26]
Atun R (2012) Health systems, systems thinking and innovation. Health Policy and Planning 27: iv4–iv8 doi:10.1093/heapol/czs1088.
[27]
Tkatchenko-Schmidt E, Atun R, Wall M, Tobi P, Schmidt J, et al. (2010) Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia. Health Policy and Planning 25: 283–291. doi: 10.1093/heapol/czq001
[28]
Wong C, Cummings G (2007) The relationship between nursing leadership and patient outcomes: a systematic review. Journal of Nursing Management 15: 508–521. doi: 10.1111/j.1365-2834.2007.00723.x
[29]
Atun R, Coker R, editors (2008) Health systems and communicable disease control: emerging evidence and lessons from central and eastern Europe. Maidenhead Open University Press, McGraw Hill Education.
[30]
Willenbring M (2005) Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS 19: S227–237. doi: 10.1097/01.aids.0000192094.84624.c2
[31]
Tkatchenko-Schmidt E, Renton A, Gevorgyan R, Davydenko L, Atun R (2008) Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes. Health Policy and Planning 85: 162–171. doi: 10.1016/j.healthpol.2007.07.005
[32]
Pablos-Mandez A, Gowda D, Frieden T (2002) Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bull World Health Organ 80: 489–500.
[33]
Atun R, Lazarus J, Van Damme W, Coker R (2010) Interactions between critical health system functions and HIV/AIDS, tuberculosis and malaria programmes Health Policy and Planning. 25: 1–3. doi: 10.1093/heapol/czq062
[34]
World Health Organisation (2007) Everybody business: strengthening health systems to improve health outcomes: WHO’s framework for action. Geneva, Switzerland. ISBN 978 92 4 159607 7: World Health Organization.
[35]
Gandhi N, Shah S, Andrews J, Vella V, Moll A, et al. (2010) HIV Co-infection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality. Amer J Resp Crit Care Med 181: 80–86. doi: 10.1164/rccm.200907-0989oc
[36]
Isaakidis P, Cox H, Varghese B, Montaldo C, Da Silva E, et al. (2011) Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India. PLoS ONE 6: e28066 doi:28010.21371/journal.pone.0028066.
[37]
Pai M, Palamountain K (2012) New tuberculosis technologies: challenges for retooling and scale-up [State of the art series. New tools. Number 4 in the series]. Int J Tuberc Lung Dis 16: 1281–1290. doi: 10.5588/ijtld.12.0391
[38]
Edward A, Kumar B, Kakar F, Salehi A, Burnham G, et al. (2011 ) Configuring Balanced Scorecards for Measuring Health System Performance: Evidence from 5 Years’ Evaluation in Afghanistan. PLoS Med 8: e1001066 doi: 1001010.1001371/journal.pmed.1001066.
[39]
Mutale W, Godfrey-Fausset P, Mwanamwenge M, Kasese N, Chintu N, et al. (2013) Measuring Health System Strengthening: Application of the Balanced Scorecard Approach to Rank the Baseline Performance of Three Rural Districts in Zambia. PLoS ONE 8: e58650 doi:58610.51371/journal.pone.0058650.
[40]
Fairall L, Zwarenstein M, Bateman E, Bachmann M, Lombard C, et al. (2005) Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial. BMJ 331: 750–754. doi: 10.1136/bmj.331.7519.750
[41]
Zwarenstein M, Fairall L, Lombard C, Mayers P, Bheekie A, et al. (2011) Outreach education for integration of HIV/AIDS care, antiretroviral treatment, and tuberculosis care in primary care clinics in South Africa: PALSA PLUS pragmatic cluster randomised trial. BMJ 342: d2022 doi:2010.1136/bmj.d2022.
[42]
Reynolds H, Toroitich-Ruto C, Nasution M, Beaston-Blaakman A, Janowitz B (2008) Effectiveness of training supervisors to improve reproductive health quality of care: a cluster-randomized trial in Kenya. Health Policy and Planning 23.
